Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients

被引:25
|
作者
Tarnow, L [1 ]
Kjeld, T [1 ]
Knudsen, E [1 ]
Major-Pedersen, A [1 ]
Parving, HH [1 ]
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
关键词
renin-angiotensin system genes; glycaemic control; diabetic nephropathy; Type I diabetes;
D O I
10.1007/s001250051377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Reports on a putative synergism between poor glycaemic control and carriage of the angiotensin II type 1 receptor (AGTR1) C-1166-allele and risk of diabetic nephropathy have been conflicting. Therefore, we investigated the interaction between long-term glycaemic control and three polymorphisms in the genes coding for AGTR1 (A(1166)-->C), angiotensin converting enzyme (ACE/ ID) and angiotensinogen (M235T) on risk of developing diabetic nephropathy. Furthermore, we investigated the relation between a random measurement and long-term measurements of haemoglobin A(1c) (HbA(1c)). Methods. We studied Caucasian patients with Type I (insulin-dependent) diabetes mellitus and nephropathy (120 men 74 women, age 41.1 +/- 9.6 years, diabetes duration 28 +/- 8 years) and long-standing Type I diabetic patients with persistent normoalbuminuria (112 men 69 women, age 42.5 +/- 10.0 years, diabetes duration 27 +/- 9 years). Genotyping was PCR-based and metabolic control estimated from all measurements of HbA(1c) done in each patient [average (range) n = 31 (6-74)]. The median observation time (range) was 13.5 (2-14) years. Results. Type I diabetic patients with a history of poor glycaemic control (HbA(1c) above the median, 8.7%) had an increased risk of diabetic nephropathy compared with patients with a better metabolic control, OR (95% CI): 9.2 (5.8-14.7). The magnitude of this risk was similar in carriers and non-carriers of the mutations. The risk of nephropathy in patients with HbA(1c) above compared with below the median in carriers of the mutant C-1166-allele, D-allele, or T235-allele were 7.6 (95% CI: 3.9-14.8), 10.4 (6.0-17.8) and 9.8 (5.4-17.9), respectively. A significant correlation (r = 0.74, p < 0.001) existed between a random and long-term measurements of HbA(1c) with a small mean difference (limits of agreement) [0.2 (-1.8 to 2.1) %] between the two estimates. Conclusian/interpretation. Poor metabolic control is a major risk factor for diabetic nephropathy in Caucasian Type I diabetic patients. This risk was similar in carriers and non-carriers of the mutant alleles of the AGTR1(A(1166)-->C), ACE/ID and angiotensinogen-M235T polymorphisms. The HbA(1c) value measured at random reflects rather closely average long-term KbA(1c) values.
引用
收藏
页码:794 / 799
页数:6
相关论文
共 47 条
  • [21] Contrasting renal functional reserve in very long-term Type I diabetic patients with and without nephropathy
    Sackmann, H
    Tran-Van, T
    Tack, I
    Hanaire-Broutin, H
    Tauber, JP
    Ader, JL
    DIABETOLOGIA, 2000, 43 (02) : 227 - 230
  • [22] C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control
    Gosek, K
    Moczulski, D
    Zukowska-Szczechowska, E
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 99 (03): : 63 - 67
  • [23] The influence of long-term glycemic control on the fibrinolytic system in type-1 diabetic patients
    Seljeflot, I
    Larsen, J
    Dahl-Jorgensen, K
    Hanssen, K
    Arnesen, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 92 - 92
  • [24] No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients
    Slowinski, T
    Diehr, P
    Kleemann, P
    Fritsche, L
    Renders, L
    Budde, K
    Hauser, IA
    Neumayer, HH
    Hocher, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2846 - 2851
  • [25] LACK OF RELATIONSHIP BETWEEN AN INSERTION DELETION POLYMORPHISM IN THE ANGIOTENSIN I-CONVERTING ENZYME GENE AND DIABETIC NEPHROPATHY AND PROLIFERATIVE RETINOPATHY IN IDDM PATIENTS
    TARNOW, L
    CAMBIEN, F
    ROSSING, P
    NIELSEN, FS
    HANSEN, BV
    LECERF, L
    POIRIER, O
    DANILOV, S
    PARVING, HH
    DIABETES, 1995, 44 (05) : 489 - 494
  • [26] Influence of gene polymorphisms and long-term glycaemic control on lipid levels in patients with metabolic syndrome and type 2 diabetes mellitus
    Stancakova, A
    Baldaufova, L
    Javorsky, M
    Kozarova, M
    Salagovic, J
    Tkac, I
    DIABETOLOGIA, 2005, 48 : A387 - A388
  • [27] Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
    Chan, JCN
    Ko, GTC
    Leung, DHY
    Cheung, RCK
    Cheung, MYF
    So, WY
    Swaminathan, R
    Nicholls, MG
    Critchley, JAJH
    Cockram, CS
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 590 - 600
  • [28] Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics
    Ceriello, A.
    Esposito, K.
    Ihnat, M.
    Thorpe, J.
    Giugliano, D.
    DIABETIC MEDICINE, 2010, 27 (08) : 911 - 917
  • [29] Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes
    Thomas, GN
    Lin, JW
    Lam, WWM
    Tomlinson, B
    Yeung, V
    Chan, JCN
    Wong, KS
    CEREBROVASCULAR DISEASES, 2003, 16 (03) : 217 - 223
  • [30] Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
    Mantovani, Alessandro
    Taverna, Antonio
    Cappelli, Davide
    Beatrice, Giorgia
    Csermely, Alessandro
    Sani, Elena
    Byrne, Christopher D.
    Targher, Giovanni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)